Amarin Corp Plc (AMRN)

[ilovetech]

I don't believe Amarin was ever conceived to be GIA company. However, It saw becoming a high valued acquisition once the company proved Icosapent Ethyl was in fact a very effective treatment as a new SOC. IMO, it doesn't matter how well Amarin shapes the messaging for prescribers, because it won't change the weekly script count. Amrn's current mission is to secure ROW buy-in, which takes a lot of time for any drug, not just EPA. Once the reimbursements are secured, and Amrn is closer to, or launches V2.0, BP knows how to exploit its own resources to shape public opinion. As for MOA, again Amrn has made it on to just about every medical association guidelines list. If Doctors are too lazy mediocre to bother looking, because they need a BP's hammer to come down on their ignorance, so be it.

ILT